Bioprospecting contributes to the discovery of new molecules with anticancer properties. Compounds with cytolytic activity and the ability to induce immunogenic cell death can be administered as ...
Boston, MA, based Investment company Mpm Asset Management Llc (Current Portfolio) buys Oncorus Inc, sells Rhythm Pharmaceuticals Inc, Harpoon Therapeutics Inc during the 3-months ended 2021Q1, ...
New production capacity strengthens MPM Medical's position as a leading U.S. manufacturer and follows the company's recent launch of collagen at-home wound care kits MESQUITE, Texas, Dec. 16, 2025 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
CAMBRIDGE, Mass. & BRISBANE, Calif.--(BUSINESS WIRE)--MPM Capital, a life-sciences venture capital firm investing in early-stage therapeutics companies, announced today the closing of its seventh ...
Jan 5 (Reuters) - Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed ...
“We are delighted to announce the addition of Detlev to our investment committee,” said Ansbert Gadicke, M.D., MPM Managing Director. “Detlev’s leadership experience combined with the depth of his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results